current dementia research australia

Different types of dementia
Dementia test and diagnosis
Treatment and management
For kids & families
How to talk about dementia
Brain health & prevention
Dementia facts & figures
Dementia: myth vs fact
Mild cognitive impairment (MCI)
What next? After your diagnosis
Caring for someone with dementia
Mood and behaviour changes
Staying healthy
Staying connected
Care options
Personal stories about living with dementia and Alzheimer's
Later stages and end of life
The National Dementia Helpline
Get peer support
Post-diagnostic support
Counselling
Family carers education
Dementia Australia Library
In your language
In your community
Ways to donate
Fundraising together for dementia
Become a Peer Leader
Corporate partnerships
Volunteer with Dementia Australia
Dementia Advocates Program
Dementia-Friendly Communities
Participate in dementia research
Professionals start here
Professional development and training
About Dementia Australia

Research news

Read the latest developments in our understanding of dementia, its causes, treatment and management.

Quick links

Find funding
Find publications
News centre
Outcomes of funding rounds
Sapphire Login
Research policy
Research priorities

More than 400,000 Australians are living with dementia. It is Australia's second overall leading cause of burden of disease in injury, behind coronary heart disease. 1 A long-term approach to the diagnosis and treatment of dementia is essential for Australia's social and economic wellbeing.

The National Health and Medical Research Council (NHMRC) remains committed to supporting dementia research in Australia.

The Australian Government's Boosting Dementia Research Initiative (BDRI) invested $200 million over five years from 2014 to 2019 to accelerate research, enhance collaboration and promote advances in dementia research and treatment. It included 11 competitive funding rounds and the establishment of the NHMRC National Institute for Dementia Research (NNIDR). All of the $200 million ‘boost’ in dementia funding has now been fully allocated and the NNIDR closed on 30 June 2020, having fulfilled its national leadership role in targeting and coordinating the strategic expansion of dementia research in Australia.

Find further information on the BDRI Grant program webpage . NNIDR activities, outputs and resources is available at  NHMRC National Institute for Dementia Research .

Recent NHMRC dementia funding news:

Dr Yijun Pan: Exploring biomarkers, therapeutic targets, and modifiable risk factors for non-Alzheimer's dementia.
Dr Chien-Hsiung Yu: Novel therapeutic strategies to intervene in tau-associated neurodegeneration by modulating tau clearance and neuroinflammation.
Dr Quan Huynh: Reducing Cognitive impairment by management of Heart Failure as a Modifiable Risk Factor: the Cog-HF trial.
Josefine Antoniades (EL1): CultureCare: Co-designing an aged care decision aid for the South Asian communities to empower informed and culturally safe decision making about aged care services.
Ibrahim Javed (EL1): Role of Gut-Bacteria in Dementia and Implications for Future Nanomedicine.
Aleksandr Kakinen (EL1): Inflammation and chronic infections in the pathogenesis of Alzheimer’s disease: the role of amyloid cross-seeding.
Elie Matar (EL1): From dreams to delirium and dementia: Cognitive fluctuations as a window into novel biomarkers and therapeutic targets for neurodegeneration.
Yijun Pan (EL1): Precise medication use in people with Alzheimer's disease.
Nady Braidy (EL2): Nicotinamide adenine dinucleotide as a novel target for ageing and dementia.
Angela D'Rozario (EL2): Investigating sleep biomarkers of cognitive impairment and improving cognitive outcomes through targeted sleep interventions in adults at risk for dementia.
Ramon Landin-Romero (EL2): Bridging the clinico-pathological divide: improving neuroimaging analysis and applications in dementia.
Nawaf Yassi (EL2): Tau - A diagnostic and therapeutic target in Alzheimer's Disease.
Professor Perminder Sachdev: Vascular Contributions to Dementia (VCD-CRE) – a transformative approach to reducing the burden of cognitive disorders.
Associate Professor Dina LoGiudice: On TRACK (Teaching, Research and Community Knowledges): CRE promoting brain health with older Aboriginal and Torres Strait Islander peoples.
Associate Professor Scott Ayton: Centre of research Excellence in Enhanced Dementia Diagnosis (CREEDD).
Further information is available at Centres of Research Excellence .
In 2022, there was an NHMRC Targeted Call for Research (TCR) funding call on ‘ Cultural, ethnic and linguistic diversity in dementia research ’ which aimed to stimulate research that includes culturally, ethnically and linguistically diverse individuals and is conducted in a culturally safe and appropriate manner.
In 2023, an additional $7 million funding was allocated towards the Ideas Grant round to support innovative dementia research projects led by early to mid-career investigators.

Funding facts

Since 2013, we have awarded over $549 million in direct funding to 496 dementia research projects. Forty-four percent of the grants have been in basic science research, followed by clinical medicine and science research (38%), public health research (10%) and health services research (8%). See the NHMRC Dementia Funding Outcomes Data (available in Downloads below) for all dementia research funded through NHMRC funding schemes since 2013.

Strategic Roadmap for Dementia Research and Translation

The Strategic Roadmap for Dementia Research and Translation (available in Downloads below) outlines the priorities for dementia research in Australia identified through the NNIDR.

Aboriginal and Torres Strait Islander Roadmap for Dementia Research and Translation

The Aboriginal and Torres Strait Islander Roadmap for Dementia Research and Translation (available in Downloads below) provides a framework for policy, strategy and funding to address the challenge of dementia within Aboriginal and Torres Strait Islander communities - for people currently living with dementia, their families and carers.

Culturally and Linguistically Diverse (CALD) Dementia Research Action Plan

The Culturally and Linguistically Diverse (CALD) Dementia Research Action Plan includes research priorities and guiding principles identified to increase inclusion of CALD Australians in dementia research, and improve dementia health and care equity for all Australians. The Action Plan was developed by the NNIDR and the National Ageing Research Institute (NARI). For further information, please refer to the NHMRC National Institute for Dementia Research .

Dementia research outcomes

We are committed to evaluating the significant $200 million BDRI investment to better understand the impact of dementia research funding and to identify areas of need for future investment in this area.

Consumer involvement in dementia research

We understand and value the importance of meaningful engagement with consumers throughout all stages of research and health care. We encourage the active involvement of people living with dementia, their carers and families, and the wider community in dementia research. More information can be found at NHMRC consumer and community engagement .

Email [email protected]

1 Australian Institute of Health and Welfare (2023) Dementia in Australia , AIHW, Australian Government

NHMRC aims to follow and meet the Web Content Accessibility Guidelines (WCAG 2.2 AA). Despite our best efforts to ensure accessibility of NHMRC’s website, we publish documents received from third parties. These documents may not meet the WCAG 2.2 AA. If you have any difficulties in accessing our content, contact us by emailing: [email protected] .

Indigenous Research Excellence Criteria video transcript
Funding agreement and deed of agreement
Institution approvals
Institutional Annual Compliance Report
Vary your grant
Financial reporting
Progress, final and additional reporting
Direct Research Cost Guidelines
Previous Personnel Support Package rates
Previous Salary Support Package rates
Institutional approvals and grant conditions
Funding Agreement
Financial Reports
Scientific reporting and milestones
Direct Research Costs and Personnel and Salary Support Packages
Eligibility
Peer review
Research funding data
Analysis of Australian health and medical research publications
Medical Research Future Fund
International Collaborative Health Research Funding
Funding calendar
Working together to support research
Statements of Expectations
Targeted Calls for Research
Capacity and capability building and strengthening
Health Advice and Publications
Health effects of water fluoridation
Preventing infection
How NHMRC develops public health guidelines
Natural Therapies Review
Electronic cigarettes
Myalgic Encephalomyelitis and Chronic Fatigue Syndrome
Lead blood levels
Recreational Water Quality Advisory Committee
Australian Guidelines to Reduce Health Risks from Drinking Alcohol - Public submissions
National Statement on Ethical Conduct in Human Research
Genomics resources for clinicians and researchers
Vitamin K for newborns
Guidelines for Guidelines
COVID-19 impacts
Clinical trials reform
Determining whether an embryo model is regulated by the ERLC
Information for applicants
Information for Licence Holders
Mitochondrial Donation Licensing Scheme
Training and Quality Assurance activities
Import and export of cell lines
Database of Licences issued
Training and Quality Assurance
Animals in NHMRC-funded research
The Human Research Ethics Applications (HREA)
Ethical issues and further resources
National Certification Scheme
Human research ethics committees
Clinical ethics
Ethical guidelines for Assisted Reproductive Technology
Ethical guidelines for research with Aboriginal and Torres Strait Islander Peoples
NHMRC ethical guidelines on organ and tissue donation and transplantation
Guideline development
International engagement
Research quality
Release of the 2018 Australian Code for the Responsible Conduct of Research
Annual NHMRC Research Translation Symposium
Recognised Health Research and Translation Centres
Research impact
Dementia research
NHMRC Special Initiative in Mental Health
NHMRC’s role in addressing health implications of environmental change
Submission of Targeted Calls for Research online pathway
NHMRC health priorities 2024–2027
Framework for Identifying and Prioritising Targeted Calls for Research
Targeted Calls for Research Prioritisation Criteria Rubric
Guide for Proposing Targeted Calls for Research
Administering Institution Policy
NHMRC Gender Equity Strategy 2022-2025
Structural priority funding and gender equity
Accountability and reporting
Fifteenth edition
Fourteenth edition
Ten of the Best Archive
Ten of the Best
2022 Research Excellence Awards
2023 Research Excellence Awards
Biennial Awards
Research Excellence Awards
Legislative basis to NHMRC
Senior executive and leadership team
Previous Committees and Advisory Groups
Publications
Probity Event - Additional Guidance
NHMRC Complaints Policy
Temporary Employment Register
Working at NHMRC
How we select our people
Indigenous internship program
Freedom of information
Child Safe Policy
Annual reports and corporate plans
Consumer and community engagement
About the review
Consumer Statement review
Consumer and community representative involvement in the peer review process of Targeted Calls for Research